Literature DB >> 19504083

Financial requirements for the treatment of diabetes in Latin America: implications for the health system and for patients in Mexico.

A Arredondo, E de Icaza.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19504083     DOI: 10.1007/s00125-009-1417-5

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  3 in total

1.  The progressive cost of complications in type 2 diabetes mellitus.

Authors:  J B Brown; K L Pedula; A W Bakst
Journal:  Arch Intern Med       Date:  1999-09-13

2.  The cost of diabetes in Latin America and the Caribbean.

Authors:  Alberto Barceló; Cristian Aedo; Swapnil Rajpathak; Sylvia Robles
Journal:  Bull World Health Organ       Date:  2003-03-11       Impact factor: 9.408

3.  The economic burden of out-of-pocket medical expenditures for patients seeking diabetes care in Mexico.

Authors:  A Arredondo; A Barceló
Journal:  Diabetologia       Date:  2007-09-19       Impact factor: 10.122

  3 in total
  3 in total

1.  Cost-effectiveness study of oral hypoglycemic agents in the treatment of outpatients with type 2 diabetes attending a public primary care clinic in Mexico City.

Authors:  Christian Díaz de León-Castañeda; Marina Altagracia-Martínez; Jaime Kravzov-Jinich; Ma del Rosario Cárdenas-Elizalde; Consuelo Moreno-Bonett; Juan Manuel Martínez-Núñez
Journal:  Clinicoecon Outcomes Res       Date:  2012-03-07

2.  Type 2 diabetes and health care costs in Latin America: exploring the need for greater preventive medicine.

Authors:  Armando Arredondo
Journal:  BMC Med       Date:  2014-08-19       Impact factor: 8.775

3.  Health disparities from economic burden of diabetes in middle-income countries: evidence from México.

Authors:  Armando Arredondo; Gabriela Reyes
Journal:  PLoS One       Date:  2013-07-12       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.